Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone ....
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Orchid Pharma Ltd has informed exchanges about a Board meeting on May 25, 2026 to consider and approve Audited Financial Results (Standalone & Consolidated) for Q4 and Financial Year 2025-26 ending March 31, 2026. The company has also confirmed that the Trading Window remains closed from April 1, 2026 and will reopen 48 hours after the results are declared. This is a standard regulatory intimation under SEBI LODR Regulation 29. The filing does not provide any financial performance details or guidance ahead of the results announcement.
This is a routine filing with no new information for investors. The actual impact on the stock will depend on the financial results announced on May 25, 2026. Trading window closure protects investors from insider trading ahead of material disclosures.